| Previous Close | 28.22 |
| Open | 28.09 |
| Bid | 28.09 x 800 |
| Ask | 28.10 x 800 |
| Day's Range | 27.81 - 28.24 |
| 52 Week Range | 20.38 - 32.08 |
| Volume | 1,740,201 |
| Avg. Volume | 4,502,032 |
| Market Cap | 20.956B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.28 |
| Earnings Date | Nov. 04, 2020 |
| Forward Dividend & Yield | 0.52 (1.84%) |
| Ex-Dividend Date | Aug. 13, 2020 |
| 1y Target Est | 30.52 |
- Simply Wall St.
Corteva, Inc.'s (NYSE:CTVA) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Corteva's (NYSE:CTVA) stock is up by 8.4% over the past three months. Given that the stock prices usually follow...
- Business Wire
AMVAC and Corteva Collaborate on SIMPAS Prescription Application Technology
American Vanguard Corporation (NYSE:AVD) announced today that its wholly owned subsidiary AMVAC Chemical Corporation completed the first phase of a testing relationship with Corteva Agriscience (NYSE: CTVA) regarding Corteva’s use of AMVAC’s proprietary SIMPAS™ prescriptive application equipment. SIMPAS allows farmers to prescriptively apply multiple at-plant solutions. The technology enabled Corteva Agriscience, a leading agriculture company focused on developing crop protection, seed, and digital solutions for farmers, to precisely deliver inputs in replicated research trials in anticipation of commercialization of Corteva-brand SIMPAS-applied Solutions™ (SaS). SIMPAS is designed to address targeted problem areas in fields with solutions that are applied to specific management zones rather than treating the entire field. The announcement follows Corteva’s successful trial work with pre-commercial SIMPAS equipment in 2020.
- Simply Wall St.
Just Four Days Till Corteva, Inc. (NYSE:CTVA) Will Be Trading Ex-Dividend
Corteva, Inc. (NYSE:CTVA) stock is about to trade ex-dividend in 4 days. Ex-dividend means that investors that...
